GNF6702
id:
gnf6702-200-2799145
title:
GNF6702
text:
GNF6702 is the name for a broad-spectrum antiprotozoal drug invented by researchers working at the Genomics Institute of the Novartis Research Foundation in 2013, with activity against leishmaniasis, Chagas disease and sleeping sickness. These three diseases are caused by related kinetoplastid parasites, which share similar biology. GNF6702 acts as allosteric proteasome inhibitor which was effective against infection with any of the three protozoal diseases in mice, while having little evident t
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/GNF6702
date created:
date modified:
2024-03-25T04:36:14Z
main entity:
{"identifier":"Q28209079","url":"https://www.wikidata.org/entity/Q28209079"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/c/cc/GNF6702_structure.png","width":686,"height":454}
fields total:
13
integrity:
15